Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health. The newly combined company has been renamed PhenomeX and its common stock will begin trading on Nasdaq under the ticker symbol "CELL" at market open tomorrow.
Q4 2022 Berkeley Lights Inc Earnings Call
The recent price decline of 11% in IsoPlexis Corporation's ( NASDAQ:ISO ) stock may have disappointed insiders who...